NCT00909298View on ClinicalTrials.gov

Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2010

Conditions
Coagulation
Interventions
DRUG

TTP889

300 mg

DRUG

Placebo

Placebo

Trial Locations (3)

10029

Mount Sinai School of Medicine, New York

10032

New York Presbyterian Hospital / Columbia University Medical Center, New York

99207

Providence Sacred Heart Medical Center and Children's Hospital, Spokane

Sponsors

Lead Sponsor

vTv Therapeutics
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

vTv Therapeutics

INDUSTRY

NCT00909298 - Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA) | Biotech Hunter | Biotech Hunter